Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2009

01.07.2009 | Preclinical Study

Three-dimensional pathological size assessment in primary breast carcinoma

verfasst von: Uwe Güth, Denise Brenckle, Dorothy Jane Huang, Andreas Schötzau, Carsten Thomas Viehl, Holger Dieterich, Wolfgang Holzgreve, Edward Wight, Gad Singer

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Maximal tumor diameter (MD) is traditionally an important prognostic factor in breast cancer. It must be questioned, however, how well a one-dimensional parameter alone can represent the actual morphologic condition of a three-dimensional body. Along with the pathologically assessed MD and two perpendicular diameters (PDs) of a lesion, eccentricity (EF) and the three-dimensional parameters tumor volume (TV) and surface area (TSA) of 395 ductal invasive breast carcinomas of limited size (10–40 mm) were calculated. The dependent prognostic variable was axillary lymph node involvement (ALNI). MD, TV and TSA area were highly significant predictors of ALNI; these variables had similar levels of prediction accuracy (univariate analyses: MD: P = 0.0003, TV: P = 0.0009, TSA: P < 0.0001; multivariate analyses: MD: P = 0.0018, TV: P = 0.0109, TSA: P = 0.0009; pseudo R-squared values: MD: 0.42, TV: 0.39, TSA: 0.39). Despite certain variations in tumor shape, TV and TSA with similar MD, there is no evidence that three-dimensional pathologic measurements (TV/TSA) are more precise prognostic predictors of ALNI compared to the one-dimensional measurement alone.
Literatur
1.
Zurück zum Zitat Chang J, Hilsenbeck S (2004) Prognostic and predictive markers. In: Harris J, Lippman M, Morrow M, Osborne K (eds) Diseases of the breast, 3rd edn. Lippincott Williams & Wilkins, Philadelphia Chang J, Hilsenbeck S (2004) Prognostic and predictive markers. In: Harris J, Lippman M, Morrow M, Osborne K (eds) Diseases of the breast, 3rd edn. Lippincott Williams & Wilkins, Philadelphia
2.
Zurück zum Zitat Michaelson JS, Silverstein M, Wyatt J et al (2002) Predicting the survival of patients with breast carcinoma using tumor size. Cancer 95(4):713–723PubMedCrossRef Michaelson JS, Silverstein M, Wyatt J et al (2002) Predicting the survival of patients with breast carcinoma using tumor size. Cancer 95(4):713–723PubMedCrossRef
3.
Zurück zum Zitat Pathology Reporting of Breast Disease (NHSBSP Publication No 58) (2005) NHS cancer screening programmes jointly with the Royal College of Pathologists. London Pathology Reporting of Breast Disease (NHSBSP Publication No 58) (2005) NHS cancer screening programmes jointly with the Royal College of Pathologists. London
5.
Zurück zum Zitat Wells C (2006) Quality assurance guidelines for pathology. In: Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L (eds) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. Office for Official Publications of the European Communities, Luxembourg Wells C (2006) Quality assurance guidelines for pathology. In: Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L (eds) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. Office for Official Publications of the European Communities, Luxembourg
6.
Zurück zum Zitat McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics) (2006) REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100(2):229–235 McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics) (2006) REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100(2):229–235
7.
Zurück zum Zitat Schwartz LH, Colville JA, Ginsberg MS et al (2006) Measuring tumor response and shape change on CT: esophageal cancer as a paradigm. Ann Oncol 17(6):1018–1023PubMedCrossRef Schwartz LH, Colville JA, Ginsberg MS et al (2006) Measuring tumor response and shape change on CT: esophageal cancer as a paradigm. Ann Oncol 17(6):1018–1023PubMedCrossRef
8.
Zurück zum Zitat Agresti A (2007) An introduction to categorical data analysis, 2nd edn. Wiley, Hoboken Agresti A (2007) An introduction to categorical data analysis, 2nd edn. Wiley, Hoboken
9.
Zurück zum Zitat Freese J, Long J (2006) Regression models for categorical dependent variables using stata, 2nd edn. Stata Pres, College Station Freese J, Long J (2006) Regression models for categorical dependent variables using stata, 2nd edn. Stata Pres, College Station
10.
Zurück zum Zitat Cho N, Moon WK, Cha JH et al (2006) Differentiating benign from malignant solid breast masses: comparison of two-dimensional and three-dimensional US. Radiology 240(1):26–32PubMedCrossRef Cho N, Moon WK, Cha JH et al (2006) Differentiating benign from malignant solid breast masses: comparison of two-dimensional and three-dimensional US. Radiology 240(1):26–32PubMedCrossRef
11.
Zurück zum Zitat Schnall MD, Blume J, Bluemke DA et al (2006) Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 238(1):42–53PubMedCrossRef Schnall MD, Blume J, Bluemke DA et al (2006) Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 238(1):42–53PubMedCrossRef
12.
Zurück zum Zitat Andea AA, Bouwman D, Wallis T, Visscher DW (2004) Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 100(1):20–27PubMedCrossRef Andea AA, Bouwman D, Wallis T, Visscher DW (2004) Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 100(1):20–27PubMedCrossRef
13.
Zurück zum Zitat Wapnir IL, Barnard N, Wartenberg D, Greco RS (2001) The inverse relationship between microvessel counts and tumor volume in breast cancer. Breast J 7(3):184–188PubMedCrossRef Wapnir IL, Barnard N, Wartenberg D, Greco RS (2001) The inverse relationship between microvessel counts and tumor volume in breast cancer. Breast J 7(3):184–188PubMedCrossRef
14.
Zurück zum Zitat Wapnir IL, Wartenberg DE, Greco RS (1996) Three dimensional staging of breast cancer. Breast Cancer Res Treat 41(1):15–19PubMedCrossRef Wapnir IL, Wartenberg DE, Greco RS (1996) Three dimensional staging of breast cancer. Breast Cancer Res Treat 41(1):15–19PubMedCrossRef
15.
Zurück zum Zitat Sleeman JP, Cremers N (2007) New concepts in breast cancer metastasis: tumor initiating cells and the microenvironment. Clin Exp Metastasis 24(8):707–715PubMedCrossRef Sleeman JP, Cremers N (2007) New concepts in breast cancer metastasis: tumor initiating cells and the microenvironment. Clin Exp Metastasis 24(8):707–715PubMedCrossRef
Metadaten
Titel
Three-dimensional pathological size assessment in primary breast carcinoma
verfasst von
Uwe Güth
Denise Brenckle
Dorothy Jane Huang
Andreas Schötzau
Carsten Thomas Viehl
Holger Dieterich
Wolfgang Holzgreve
Edward Wight
Gad Singer
Publikationsdatum
01.07.2009
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2009
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0115-1

Weitere Artikel der Ausgabe 2/2009

Breast Cancer Research and Treatment 2/2009 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.